Importance of Adaptive and Stepwise Changes in the Rise and Spread of Antimicrobial Resistance

Antimicrobial Resistance in the Environment

Volumn , Issue , 2011, Pages 43-71

  Fernandez, Lucia ^a   Breidenstein, Elena B M ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adaptive resistance triggers, and resistance phenotype; Antimicrobial resistance, adaptive, stepwise changes; Intrinsic resistome and mutational resistome

Indexed keywords

EID: 84867162416     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118156247.ch5     Document Type: Chapter

References (122)

1. Alvarez-Ortega C, Wiegand I, Olivares J, Hancock REW, Martinez JL (2010). Genetic determinats involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob Agents Chemother 54(10):4159-4167.
2. Anderl JN, Franklin MJ, Stewart PS (2000). Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 44(7):1818-1824.
3. Bagge N, Schuster M, Hentzer M, Ciofu O, Givskov M, Greenberg EP, Høiby N (2004). Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 48(4):1175-1187.
4. Barber M, Waterworth PM (1966). Activity of gentamicin against Pseudomonas and hospital staphylococci. Br Med J 1(5481):203-205.
5. Barclay ML, Begg EJ, Chambers ST, Thornley PE, Pattemore PK, Grimwood K (1996). Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis. Antimicrob Chemother 37(6):1155-1164.
6. Baquero F (2001). Low-level antibacterial resistance: A gateway to clinical resistance. Drug Resist Updat 4(2):93-105.
7. Bjarnsholt T, Jensen PØ, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, Pressler T, Givskov M, Høiby N (2009). Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44(6):547-558.
8. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS (2004). Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 48(7):2659-2664.
9. Brazas MD, Hancock REW (2005a). Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. Drug Discov Today 10(18):1245-1252. Brazas MD, Hancock REW (2005b). Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49(8):3222-3227.
10. Brazas MD, Hancock REW (2005b). Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49(8):3222-3227.
11. Brazas MD, Breidenstein EBM, Overhage J, Hancock REW (2007). Role of lon, an ATPdependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin. Antimicrob Agents Chemother 51(12):4276-4283.
12. Breidenstein EBM, Khaira BK, Wiegand I, Overhage J, Hancock REW (2008). Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob Agents Chemother 52(12):4486-4491.
13. Brown MR, Allison DG, Gilbert P (1988). Resistance of bacterial biofilms to antibiotics: A growth-rate related effect? J Antimicrob Chemother 22(6):777-780.
14. Butler MT, Wang Q, Harshey RM (2010). Cell density and mobility protect swarming bacteria against antibiotics. Proc Natl Acad Sci USA 107(8):3776-3781.
15. Celli J, Trieu-Cuot P (1998). Circularization of Tn916 is required for expression of the transposon-encoded transfer functions: Characterization of long tetracycline-inducible transcripts reading through the attachment site. Mol Microbiol 28(1):103-117.
16. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR, Schweizer HP (2001). Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: Exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 45(2):428-432.
17. Ciofu O, Riis B, Pressler T, Poulsen H, Hoiby N (2005). Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 49(6):2276-2282.
18. Cirz RT, O'Neill BM, Hammond JA, Head SR, Romesberg FE (2006). Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J Bacteriol 188(20):7101-7110.
19. Daikos GL, Lolans VT, Jackson GG (1991). First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrobial Agents Chemother 35(1):117-123.
20. Davey ME, O'Toole GA (2000). Microbial biofilms: From ecology to molecular genetics. Microbiol Mol Biol Rev 64(4):847-867.
21. Dibb WL, Asphaug Kjellevold V, Digranes A (1983). Pseudomonas aeruginosa and Acinetobacter calcoaceticus: In vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin. Chemotherapy 29(5):332-326.
22. Donlan RM (2001). Biofilms and device-associated infections. Emerg Infect Dis 7(2):277-281.
23. Dotsch A, Becker T, Pommerenke C, Magnowska Z, Jänsch L, Häussler S (2009). Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53(6):2522-2531.
24. Driffield K, Miller K, Bostock JM, O'Neill AJ, Chopra I (2008). Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother 61(5):1053-1056. Dubern JF, Diggle SP (2008). Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species. Mol Biosyst 4(9):882-888.
25. Dubern JF, Diggle SP (2008). Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species. Mol Biosyst 4(9):882-888.
26. El'Garch F, Jeannot K, Hocquet D, Llanes-Barakat, Plesiat P (2007). Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 51(3):1016-1021.
27. Ernst RL, Yi EC, Guo L, Lim KB, Burns JL, Hackett M, Miller SI (1999). Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286(5444):1561-1565.
28. Ernst RK, Moskowitz SM, Emerson JC, Kraig GM, Adams KN, Harvey MD, Ramsey B, Speert DP, Burns JL, Miller SI (2007). Unique lipid A modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. J Infecti Dis 196(7):1088-1092.
29. Fajardo A, Martinez-Martin N, Mercadillo M, Galan JC, Ghysels B, Matthijs S, Cornelis P, Wiehlmann L, Baquero F, Martinez JL (2008). The neglected intrinsic resistome of bacterial pathogens. PloS ONE 3(2):e1619.
30. Fernández L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock REW (2010). Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother 54(8):3372-3382.
31. Fraser GM, Hughes C (1999). Swarming motility. Curr Opin Microbiol 2(6):630-635.
32. Garau G, Di Guilmi AM, Hall BG (2005). Structure-based phylogeny of the metallo-ß- lactamases. Antimicrob Agents Chemother 49(7):2778-2784.
33. Gerber AU, Craig WA (1982). Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: Characterization and virulence in normal and leukopenic mice. J Lab Clin Med 100(5):671-681.
34. Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW (2002). The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 46:202-256.
35. Gilleland LB, Gilleland HE, Gibson JA, Champlin FR (1989). Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. J Med Microbiol 29(1):41-50.
36. Gillis RJ, White KG, Choi KH, Wagner VE, Schweizer HP, Iglewski BH (2005). Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 49(9):3858-3867.
37. Gooderham WJ, Hancock REW (2009). Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol Rev 33 (2):279-294.
38. Guisbert E, Yura T, Rhodius VA, Gross CA (2008). Convergence of molecular, modeling, and systems approaches for an understanding of the Escherichia coli heat shock response. Microbiol Mol Biol Rev 72(3):545-554.
39. Hall BG, Barlow M (2004). Evolution of the serine ß-lactamases: Past, present and future. Drug Resist Updat 7(2):111-123.
40. Hancock REW (1981). Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. I. Antagonists and mutants. J Antimicrob Chemother 8(4):429-445.
41. Hanson ND, Sanders CC (1999). Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae. Curr Pharm Des 5(11):881-894.
42. Hastings PJ, Rosenberg SM, Slack A (2004). Antibiotic-induced lateral transfer of antibiotic resistance. Trends Microbiol 12(9):401-404.
43. Hausner M, Wuertz S (1999). High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol 65(8):3710-3713.
44. Hegstad K, Langsrud S, Lunestad BT, Scheie AA, Sunde M, Yazdankhah SP (2010). Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health? Microb Drug Resist 16(2):91-104.
45. Hocquet D, Vogne C, El Garch F, Vejux A, Gotoh N, Lee A, Lomovskaya O, Plésiat P (2003). MexXY-OprM efflux pump is necessary for adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother 47(4):1371-1375.
46. Hoyle BD, Costerton JW (1991). Bacterial resistance to antibiotics: The role of biofilms. Prog Drug Res 37:91-105.
47. Hoyle BD, Alcantara J, Costerton JW (1992). Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrob Agents Chemother 36(9):2054-2056.
48. Jalal S, Wretlind B (1998). Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microb Drug Resist 4(4):257-261.
49. Jalal S, Ciofu O, Hoiby N, Gotoh N, Wretlind B (2000). Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 44(3):710-712.
50. Karlowsky JA, Hoban DJ, Zelenitsky SA, Zhanel GG (1997). Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosa. J Antimicrob Chemother 40(3):371-376.
51. Kaufmann GF, Sartorio R, Lee SH, Rogers CJ, Meijler MM, Moss JA, Clapham B, Brogan AP, Dickerson TJ, Janda KD (2005). Revisiting quorum sensing: Discovery of additional chemical and biological functions for 3-oxo-N-acylhomoserine lactones. Proc Natl Acad Sci USA 102(2):309-314.
52. Kenna DT, Doherty CJ, Foweraker J, Macaskill L, Barcus VA, Govan JR (2007). Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis. Microbiology 153(Pt6):1852-1859.
53. Kim W, Surette MG (2003). Swarming populations of Salmonella represent a unique physiological state coupled to multiple mechanisms of antibiotic resistance. Biol Proced Online 5:189-196.
54. Kim W, Killam T, Sood V, Surette MG (2003). Swarm-cell differentiation in Salmonella enterica serovar Typhimurium results in elevated resistance to multiple antibiotics. J Bacteriol 185(10):3111-3117.
55. Kindrachuk KN, Fernández L, Bains M, Hancock REW (2011). Involvement of an ATPdependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55(5):1874-1882.
56. Kirketerp-Møller K, Jensen PØ, Fazli M, Madsen KG, Pedersen J, Moser C, Tolker-Nielsen T, Høiby N, Givskov M, Bjarnsholt T (2008). Distribution, and ecology of bacteria in chronic wounds. J Clin Microbiol 46(8):2717-2722.
57. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007). A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130(5):797-810.
58. Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ (2008). Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135(4):679-690.
59. Kumon H, Tomochika K, Matunaga T, Ogawa M, Ohmori H (1994). A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides. Microbiol Immunol 38(8):615-619.
60. Lai S, Tremblay J, Déziel E (2008). Swarming motility: A multicellular behaviour conferring antimicrobial resistance. Environ Microbiol 11(1):126-136.
61. Lee S, Hinz A, Bauerle E, Angermeyer A, Juhaszova K, Kaneko Y, Singh PK, Manoil C (2009). Targeting a bacterial stress response to enhance antibiotic action. Proc Natl Acad Sci USA 106(34):14570-14575.
62. Lewenza S, Falsafi RK, Winsor G, Gooderham WJ, McPhee JB, Brinkman FS, Hancock REW (2005). Construction of a mini-Tn5-luxCDABE mutant library in Pseudomonas aeruginosa PAO1: A tool for identifying differentially regulated genes. Genome Res 15(4):583-589.
63. Lewis K (2008). Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 322:107-131.
64. Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E, Wu G, Villanueva J, Wei T, Ausubel FM (2006). An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci USA 103(8):2833-2838.
65. Lin JT, Connelly MB, Amolo C, Otani S, Yaver DS (2005). Global transcriptional response of Bacillus subtilis to treatment with subinhibitory concentrations of antibiotics that inhibit protein synthesis. Antimicrob Agents Chemother 49(5):1915-1926.
66. Linares JF, Gustafsson I, Baquero F, Martinez JL (2006). Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci USA 103(51):19484-19489.
67. Lindberg F, Normark S (1986). Contribution of chromosomal ß-lactamases to ß-lactam resistance in enterobacteria. Rev Infect Dis 8(Suppl. 3):S292-304.
68. Livermore DM (1987). Clinical significance of ß-lactamase induction and stable derepression in gram-negative rods. Eur J Clin Microbiol 6(4):439-445.
69. Livermore DM (1996). Are all beta-lactams created equal? Scand J Infect Dis Suppl 101: 33-43.
70. Loh B, Grant C, Hancock REW(1984). Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 26(4):546-551.
71. Macfarlane EL, Kwasnicka A, Ochs MM, Hancock REW (1999). PhoPQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol Microbiol 34(2):305-316.
72. MacLeod DL, Nelson LE, Shawar RM, Lin BB, Lockwood LG, Dirks JE, Miller GH, Burns JL, Garber RL (2000). Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J Infect Dis 181(3):1180-1184.
73. Marr AK, Overhage J, Bains M, Hancock REW (2007). The Lon protease of Pseudomonas aeruginosa is induced by aminoglycosides and is involved in biofilm formation and motility. Microbiology 153(2):474-482.
74. Mates SM, Eisenberg ES, Mandel LJ, Patel L, Kaback HR, Miller MH (1982). Membrane potential and gentamicin uptake in Staphylococcus aureus. Proc Natl Acad Sci USA 79(21):6693-6697.
75. Mawer SL, Greenwood D (1978). Specific and non-specific resistance to aminoglycosides in Escherichia coli. J Clin Pathol 31(1):12-15.
76. McKenzie GJ, Lee PL, Lombardo M-J, Hastings PJ, Rosenberg SM (2001). SOS mutator DNA polymerase IV functions in adaptive mutation and not adaptive amplification. Mol Cell 7(3):571-579.
77. McMurry LM, Oethinger M, Levy SB (1998). Overexpression of marA, soxS or acrAB produces resistance to triclosan in Escherichia coli. FEMS Microbiol Lett 166(2):305-309.
78. McPhee JB, Lewenza S, Hancock REW (2003). Cationic antimicrobial peptides activate a twocomponent regulatory system, PmrAB. That regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 50(1):205-217.
79. Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H, Cohen SN (2004). SOS response induction by ß-lactams and bacterial defense against antibiotic lethality. Science 305(5690):1629-1631.
80. Molin S, Tolker-Nielsen T (2003). Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol 14(3): 255-261.
81. Mulcahy H, Charron-Mazenod L, Lewenza S (2008). Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathogens 4(11): e1000213.
82. Mulcahy LR, Burns JL, Lory S, Lewis K (2010). Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192(23):6191-6199.
83. Nakayama K, Takashima K, Ishihara H, Shinomiya T, Kageyama M, Kanaya S, Ohnishi M, Murata T, Mori H, Hayashi T (2000). The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol Microbiol 38(2): 213-231.
84. Nalca Y, Jänsch L, Bredenbruch F, Geffers R, Buer J, Häussler S (2006). Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: A global approach. Antimicrob Agents Chemother 50(5):1680-1688.
85. Nickel JC, Wright JB, Ruseska I, Marrie TJ, Whitfield C, Costerton JW (1985). Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro. Eur J Clin Microbiol 4(2):213-218.
86. Normark S, Lindquist S, Lindberg F (1986). Chromosomal beta-lactam resistance in enterobacteria. Scand J Infect Dis Suppl 49:38-45.
87. Oliver A, Canton R, Campo P, Baquero F, Blazquez J (2000). High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288(5469):1251-1254.
88. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock REW(2008a). Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76(9):4176-4182.
89. Overhage J, Bains M, Brazas MD, Hancock REW (2008b). Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J Bacteriol 190(8):2671-2679.
90. Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW (2004). Epidemiology and clinical features of bloodstream infections caused by AmpCREFERENCES type-ß-lactamases-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 48(10): 3720-3728.
91. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T (2008). Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 68(1): 223-240.
92. Poole K (2001). Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol 3(2):255-264.
93. Poole K (2004). Resistance to ß-lactam antibiotics. Cell Mol Life Sci 61(17):2200-2223. Potvin E, Sanschagrin F, Levesque RC (2008). Sigma factors in Pseudomonas aeruginosa. FEMS Microbiol Rev 32(1):38-55.
94. Potvin E, Sanschagrin F, Levesque RC (2008). Sigma factors in Pseudomonas aeruginosa. FEMS Microbiol Rev 32(1):38-55.
95. Privitera G, Sebald M, Fayolle F (1979). Common regulatory mechanism of expression and conjugative ability of a tetracycline resistance plasmid in Bacteroides fragilis. Nature 278(5705):657-659.
96. Pumbwe L, Piddock LJV (2000). Two efflux systems expressed simultaneously in multidrugresistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 44(10):2861-2864.
97. Sánchez P, Linares JF, Ruiz-Díez B, Campanario E, Navas A, Baquero F, Martínez JL (2002). Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J Antimicrob Chemother 50(5):657-664. Sanders CC (1993). Cefepime: The next generation? Clin Infect Dis 17(3):369-379.
98. Sanders CC (1993). Cefepime: The next generation? Clin Infect Dis 17(3):369-379.
99. Schurek KN, Marr AK, Taylor PK, Wiegand I, Semenec L, Khaira BK, Hancock REW (2008). Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 52(12):4213-4219.
100. Schurek KN, Sampaio JL, Kiffer CR, Sinto S, Mendes CM, Hancock REW (2009). Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 53(10):4345-4351.
101. Schurr MJ, Deretic V (1997). Microbial pathogenesis in cystic fibrosis: Co-ordinate regulation of heat-shock response and conversion to mucoidy in Pseudomonas aeruginosa. Mol Microbiol 24(2):411-420.
102. Schweizer HP (2003). Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: Unanswered questions. Genet Mol Res 31;2(1):48-62.
103. Shaw KJ, Miller N, Liu X, Lerner D, Wan J, Bittner A, Morrow BJ (2003). Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents. J Mol Microbiol Biotechnol 5(2):105-122.
104. Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T (1997). Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: A simple method. Chemotherapy 43(5):340-345.
105. Shimohata N, Chiba S, Saikawa N, Ito K, Akiyama Y (2002). The Cpx stress response system of Escherichia coli senses plasma membrane proteins and controls HtpX, a membrane protease with a cytosolic active site. Genes to Cells 7(7):653-662.
106. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV (2006). Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 30;103(22):8487-8492.
107. Steinkraus G, White R, Friedrich L (2007). Vancomycin MIC creep in non-vancomycinintermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillinresistant S. aureus (MRSA) blood isolates from 2001-2005. J Antimicrob Chemother 60(4): 788-794.
108. Stock AM, Robinson VL, Goudreau PN (2000). Two-component signal transduction. Annu Rev Biochem 69:183-215.
109. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock- Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock REW, Lory S, Olson MV (2000). Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406(6799):959-964.
110. Suci PA, Mittelman MW, Yu FP, Geesey GG (1994). Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 38(9):2125-2133.
111. Taber HW, Mueller JP, Miller PF, Arrow AS (1987). Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 51(4):439-457.
112. Turnbull AL, Surette MG (2008). L-Cysteine is required for induced antibiotic resistance in actively swarming Salmonella enterica serovar Typhimurium. Microbiology 154(11): 3410-3419.
113. Verstraeten N, Braeken K, Debkumari B, Fauvart M, Fransaer J, Vermant J, Michiels J (2008). Living on a surface: Swarming and biofilm formation. Trends Microbiol 16(10): 496-506.
114. Vrany JD, Stewart PS, Suci PA (1997). Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa biofilms displaying rapid-transport characteristics. Antimicrob Agents Chemother 41(6):1352-1358.
115. Walsh C (2003). Antibiotics that act on cell wall biosynthesis. In C Walsh (Ed.), Antibiotics: Actions, Origins, Resistance. ASM Press, Washington, DC, pp. 23-49.
116. Wang Q, Frye JG, McClelland M, Harshey RM (2004). Gene expression patterns during swarming in Salmonella typhimurium: Genes specific to surface growth and putative new motility and pathogenicity genes. Mol Microbiol 52(1):169-187.
117. Weinstein MJ, Drube CG, Moss EL Jr, Waitz JA (1971). Microbiologic studies related to bacterial resistance to gentamicin. J Infect Dis 124:S11-17.
118. Wells IC (1952). Antibiotic substances produced by Pseudomonas aeruginosa; syntheses of Pyo Ib, Pyo Ic, and Pyo III. J Biol Chem 196(1):331-340.
119. Westbrock-Wadman S, Sherman DR, Hickey MJ, Coulter SN, Zhu YQ, Warrener P, Nguyen LY, Shawar RM, Folger KR, Stover CK (1999). Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob Agents Chemother 43(12):2975-2983.
120. Wiegand I, Marr AK, Breidenstein EBM, Schurek KN, Taylor P, Hancock REW (2008). Mutator genes giving rise to decreased antibiotic susceptibility in Pseudomonas aeruginosa. Antimicrob Agents Chemother 52(10):3810-3813.
121. Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T (1993). Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 37(9):1749-1755.
122. Zhang L, Mah TF (2008). Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 190(13):4447-4452.